PMID: 6972746Jun 1, 1981Paper

Digoxin and propranolol in the prophylaxis of supraventricular tachydysrhythmias after coronary artery bypass surgery

The Annals of Thoracic Surgery
J A Roffman, A Fieldman

Abstract

Supraventricular tachydysrhythmia is a bothersome and potentially harmful occurrence after coronary artery bypass graft operation (CABG). Use of digoxin prophylaxis preoperatively has yielded conflicting results in lowering the incidence of supraventricular tachydysrhythmia. In this study, three groups of patients were formed. Group 1 served as the control; no prophylactic medication was given. Group 2 was given digoxin prophylaxis beginning immediately after operation. Group 3 received digoxin postoperatively as did Group 2, plus orally administered propranolol beginning on postoperative day 2. No difference in the incidence of supraventricular tachydysrhythmia was found between Groups 1 and 2 (28.2% versus 28.9%). However, the incidence in Group 3 was 2.2%, and this represented a statistically significant difference (p less than 0.005) compared with either Group or 2. The combined use of digoxin and propranolol postoperatively significantly reduced the incidence of supraventricular tachydysrhythmia after CABG.

References

Sep 1, 1978·The Annals of Thoracic Surgery·H BoudoulasJ S Vasko
Apr 1, 1979·Clinical Cardiology·H BoudoulasJ S Vasko
Feb 1, 1978·The Annals of Thoracic Surgery·M M KirshH Sloan
Nov 23, 1976·The American Journal of Cardiology·E L JonesC R Hatcher
May 1, 1976·Circulation·L W JohnsonR H Eich
Mar 1, 1974·Progress in Cardiovascular Diseases·P AngeliniR D Leachman
Apr 1, 1972·British Heart Journal·P Ghosh, B C Pakrashi
Oct 1, 1972·The Annals of Thoracic Surgery·S O Burman
May 1, 1971·British Heart Journal·D J ColtartT W Smith
Feb 1, 1980·The Annals of Thoracic Surgery·L W StephensonM E Josephson
Aug 1, 1965·American Heart Journal·T KILLIP, J H GAULT

❮ Previous
Next ❯

Citations

Mar 17, 1999·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Y TeradaY Sakakibara
Jan 1, 1995·Journal of the American College of Cardiology·L A MendesR Davidoff
Apr 16, 1998·Journal of Electrocardiology·J E Tamis, J S Steinberg
Jun 1, 1984·Journal of the American College of Cardiology·P KuanM H Ellestad
Jun 1, 1997·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·I M AliV Clark
Nov 14, 1997·Annals of Surgery·G H AlmassiK E Hammermeister
Dec 1, 1992·Pacing and Clinical Electrophysiology : PACE·B OlshanskyR J Hariman
Aug 13, 2011·Clinical Medicine Insights. Cardiology·Feridoun SabziAbdol Rasoul Moloudi
Apr 14, 2006·Expert Opinion on Drug Safety·Juan TamargoRicardo Caballero
Dec 24, 1997·Cardiology Clinics·F A Masoudi, N Goldschlager
Jun 1, 1994·Chest·W Van MieghemM G Demedts
Sep 1, 1993·The Annals of Thoracic Surgery·T O Cheng
Dec 30, 2008·Cardiology Clinics·Krit Jongnarangsin, Hakan Oral
Feb 1, 2005·The Annals of Thoracic Surgery·Robert J DiDomenico, Malek G Massad
Feb 25, 2000·Journal of Electrocardiology·S ReddyJ Steinberg
May 24, 2000·The American Journal of Cardiology·D B Bharucha, P R Kowey
Oct 1, 1982·The Annals of Thoracic Surgery·J B WilliamsM E Josephson
Sep 1, 1986·The American Journal of Cardiology·F E DixonJ Landry
Apr 6, 2004·The Annals of Thoracic Surgery·James S KalusJeffrey Kluger
Dec 7, 2007·The Medical Clinics of North America·Krit Jongnarangsin, Hakan Oral
Aug 31, 1987·The American Journal of Cardiology·S F KhuriA Y Olukotun
Dec 23, 2017·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Chuang-Yan WuJia-Hong Xia
May 30, 1998·Pacing and Clinical Electrophysiology : PACE·J KassotisJ A Reiffel
Nov 12, 2009·Cardiovascular Therapeutics·Javad KojuriMahammad Bagher Sharifkazemi
Sep 12, 2007·International Journal of Mental Health Nursing·Keri de Carlo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.